Inhaled anesthetics do not combine to produce synergistic effects regarding minimum alveolar anesthetic concentration in rats

Anesthesia and Analgesia

Volumn 107, Issue 2, 2008, Pages 479-485

  Eger, Edmond I ^a,g   Tang, Michael ^a   Liao, Mark ^a   Laster, Michael J ^a   Solt, Ken ^b,c   Flood, Pamela ^d   Jenkins, Andrew ^e   Raines, Douglas ^b,c   Hendrickx, Jan F ^f   Shafer, Steven L ^g   Yasumasa, Tanifuji ^h   Sonner, James M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f STANFORD UNIVERSITY   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ANESTHETIC AGENT; BENZENE; CHLOROFORM; CHOLINERGIC RECEPTOR; CYCLOPROPANE; DESFLURANE; DIZOCILPINE; GLYCINE RECEPTOR; HALOTHANE; ISOFLURANE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITROUS OXIDE; POTASSIUM CHANNEL; SEVOFLURANE; XENON; 4 AMINOBUTYRIC ACID RECEPTOR; INHALATION ANESTHETIC AGENT; POTASSIUM CHANNEL PROTEIN TREK 1; POTASSIUM CHANNEL PROTEIN TREK-1; TANDEM PORE DOMAIN POTASSIUM CHANNEL;

ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG POTENCY; IMMOBILIZATION; IN VITRO STUDY; MALE; MINIMUM LUNG ALVEOLUS CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; DRUG EFFECT; DRUG POTENTIATION; LUNG ALVEOLUS; METABOLISM; SPRAGUE DAWLEY RAT;

ANESTHETICS, INHALATION; ANIMALS; DRUG SYNERGISM; IMMOBILIZATION; ISOFLURANE; NITROUS OXIDE; POTASSIUM CHANNELS, TANDEM PORE DOMAIN; PULMONARY ALVEOLI; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CHOLINERGIC; RECEPTORS, GABA; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 49949094585     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000295805.70887.65     Document Type: Article

References (46)

1. Sonner JM, Antognini JF, Dutton RC, Flood P, Gray AT, Harris RA, Homanics GE, Kendig JJ, Orser BA, Raines DE, Trudell JR, Vissel B, Eger EI II. Inhaled anesthetics and immobility: Mechanisms, mysteries, and MAC. Anesth Analg 2003;97:718 - 40
2. Hendrickx JFA, Eger EI II, Sonner JM, Shafer SL. Is synergy the rule? A review of anesthetic drug interactions producing hypnosis and immobility. Anesth Analg 2008;107:494-506
3. Shafer SL, Hendrickx JFA, Flood P, Sonner J, Eger EI II. Additivity-versus synergy: a theoretical analysis of implications for anesthetic mechanisms. Anesth Analg 2008;107:507-24
4. Harrison NL, Kugler JL, Jones MV, Greenblatt EP, Pritchett DB.Positive modulation of human --aminobutyric acid type A and glycine receptors by the inhalation anesthetic isoflurane. Mol Pharmacol 1993;44:628-32
5. Hara K, Eger EI II, Laster MJ, Harris RA. Nonhalogenated alkanes cyclopropane and butane affect neurotransmitter-gated ion channel and G-protein-coupled receptors: Differential actions on GABA(A) and glycine receptors. Anesthesiology 2002;97:1512-20
6. Mihic SJ, Ye Q, Wick MJ, Koltchine VV, Krasowski MD, Finn SE, Mascia MP, Valenzuela CF, Hanson KK, Greenblatt EP, Harris RA, Harrison NL. Sites of alcohol and volatile anaesthetic action on GABAA and glycine receptors. Nature 1997;389:385-9
7. Solt K, Eger EI II, Raines DE. Differential modulation of human .-methyl-d-aspartate receptors by structurally diverse general anesthetics. Anesth Analg 2006;102:1407-11
8. Jenkins A, Lobo I, Gong D, Solt K, Harris RA, Eger EI II. General anesthetics have additive actions on 3 ligand gated ion channels. Anesth Analg 2008;107:186-93
9. Heurteaux C, Guy N, Laigle C, Blondeau N, Duprat F, Mazzuca M, Lang-Lazdunski L, Widmann C, Zanzouri M, Romey G, Lazdunski M. TREK-1, a K(-) channel involved in neuroprotection and general anesthesia. EMBO J 2004;23:2684-95
10. Patel AJ, Honore E. Anesthetic-sensitive 2P domain K- channels. Anesthesiology 2001;95:1013-21
11. Gruss M, Bushell TJ, Bright DP, Lieb WR, Mathie A, Franks NP. Two-pore-domain K- channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane. Mol Pharmacol 2004;65:443-52
12. Raines DE, Gioia F, Claycomb RJ, Stevens RJ. The .-methyl- daspartate receptor inhibitory potencies of aromatic inhaled drugs of abuse: evidence for modulation by cation-pi interactions. J Pharmacol Exp Ther 2004;311:14-21
13. Yamashita M, Mori T, Nagata K, Yeh JZ, Narahashi T. Isoflurane modulation of neuronal nicotinic acetylcholine receptors expressed in human embryonic kidney cells. Anesthesiology 2005;102:76-84
14. Eger EI II, Liao M, Laster MJ, Won A, Popovich J, Raines DE, Solt K, Dutton RC, Cobos FV, Sonner JM. Contrasting roles of the .-methyl-d- aspartate receptor in the production of immobilization by conventional and aromatic anesthetics. Anesth Analg 2006;102:1397-406
15. Russell GB, Graybeal JM. Nonlinear additivity of nitrous oxide and isoflurane potencies in rats. Can J Anaesth 1998;45:466 -70
16. Graham MD, Hopkins PM, Harrison SM. Antagonistic actions of halothane and sevoflurane on spontaneous Ca2- release in rat ventricular myocytes. Anesthesiology 2006;105:58-64
17. Eger EI II, Laster MJ. The effect of rigidity, shape, unsaturation, and length on the anesthetic potency of hydrocarbons. Anesth Analg 2001;92:1477-82
18. Laster MJ, Liu J, Eger EI II, Taheri S. Electrical stimulation as a substitute for the tail clamp in the determination of MAC. Anesth Analg 1993;76:1310-2
19. Taheri S, Halsey MJ, Liu J, Eger EI II, Koblin DD, Laster MJ. What solvent best represents the site of action of inhaled anesthetics in humans, rats and dogs? Anesth Analg 1991;72:627-34
20. Gonsowski CT, Eger EI II. Nitrous oxide minimum alveolar anesthetic concentration in rats is greater than previously reported. Anesth Analg 1994;79:710-2
21. Fang ZX, Ionescu P, Chortkoff BS, Kandel L, Sonner J, Laster MJ, Eger EI II. Anesthetic potencies of .-alkanols: Results of additivity studies suggest a mechanism of action similar to that for conventional inhaled anesthetics. Anesth Analg 1997;84:1042-8
22. DiFazio CA, Brown RE, Ball CG, Heckel CG, Kennedy SS. Additive effects of anesthetics and theories of anesthesia. Anesthesiology 1972;36:57-63
23. Miller RD, Wahrenbrock EA, Schroeder CF, Knipstein TW, Eger EI II, Buechel DR. Ethylene-halothane anesthesia: Addition or synergism? Anesthesiology 1969;31:301-4
24. Eger EI II, Xing Y, Laster M, Sonner J, Antognini JF, Carstens E. Halothane and isoflurane have additive MAC effects in rats. Anesth Analg 2003;96:1350-3
25. Cullen SC, Eger EI II, Cullen BF, Gregory P. Observations on the anesthetic effect of the combination of xenon and halothane. Anesthesiology 1969;31:305-9
26. Cole DJ, Kalichman MW, Shapiro HM, Drummond JC. The nonlinear potency of sub-MAC concentrations of nitrous oxide in decreasing the anesthetic requirement of enflurane, halothane, and isoflurane in rats. Anesthesiology 1990;73:93-9
27. Hornbein TF, Eger EI II, Winter PM, Smith G, Wetstone D, Smith KH. The minimum alveolar concentration of nitrous oxide in man. Anesth Analg 1982;61:553-6
28. Saidman LJ, Eger EI II. Effect of nitrous oxide and of narcotic premedication on the alveolar concentration of halothane required for anesthesia. Anesthesiology 1964;25:302-6
29. Stevens WC, Dolan WM, Gibbons RT, White A, Eger EI II, Miller RD, de Jong RJ, Elashoff RM. Minimum alveolar concentrations (MAC) of isoflurane with and without nitrous oxide in patients of various ages. Anesthesiology 1975;42:197-200
30. Rampil IJ, Lockhart S, Zwass M, Peterson N, Yasuda N, Eger EI II, Weiskopf RB, Damask MC. Clinical characteristics of desflurane in surgical patients: Minimum alveolar concentration. Anesthesiology 1991;74:429-33
31. Katoh T, Ikeda K. The minimum alveolar concentration (MAC) of sevoflurane in humans. Anesthesiology 1987;66:301-3
32. Torri G, Damia G, Fabiani ML. Effect of nitrous oxide on the anaesthetic requirement of enflurane. Br J Anaesth 1974;46:468-72
33. Munson ES, Saidman LJ, Eger EI II. Effect of nitrous oxide and morphine on the minimum anesthetic concentration of fluroxene. Anesthesiology 1965;26:134-9
34. Nakahara T, Akazawa T, Nozaki J, Sasaki Y. [Effect of nitrous oxide at sub-MAC concentrations on sevoflurane MAC in adults]. Masui 1997;46:607-12
35. Goto T, Nakata Y, Ishiguro Y, Niimi Y, Suwa K, Morita S. Minimum alveolar concentration-awake of xenon alone and in combination with isoflurane or sevoflurane. Anesthesiology 2000;93:1188-93
36. Chortkoff BS, Bennett HL, Eger EI II. Does nitrous oxide antagonize isoflurane-induced suppression of learning? Anesthesiology 1993;79:724-32
37. Kissin I. Anesthetic interactions following bolus injections. J Clin Anesth 1997;9:14S-17S
38. Katoh T, Kobayashi S, Suzuki A, Iwamoto T, Bito H, Ikeda K. The effect of fentanyl on sevoflurane requirements for somatic and sympathetic responses to surgical incision. Anesthesiology 1999;90:398-405
39. Hecker BR, Lake CL, DiFazio CA, Moscicki JC, Engle JS. The decrease of the minimum alveolar anesthetic concentration produced by sufentanil in rats. Anesth Analg 1983;62:987-90
40. Stone DJ, Moscicki JC, DiFazio CA. Thiopental reduces halothane MAC in rats. Anesth Analg 1992;74:542-6
41. Sumikura H, Arendt-Nielsen L. MAC reduction after intrathecal coadministration of GABA(A) agonist and glutamate antagonist in rats. J Anesth 2003;17:92-7
42. Hecker KE, Horn N, Baumert JH, Reyle-Hahn SM, Heussen N, Rossaint R. Minimum alveolar concentration (MAC) of xenon in intubated swine. Br J Anaesth 2004;92:421-4
43. Hecker KE, Baumert JH, Horn N, Reyle-Hahn M, Heussen N, Rossaint R. Minimum anesthetic concentration of sevoflurane with different xenon concentrations in swine. Anesth Analg 2003;97:1364-9
44. Zhang Y, Sonner JM, Eger EI II, Stabernack CR, Laster MJ, Raines DE, Harris RA. GABAA receptors do not mediate the immobility produced by inhaled anesthetics. Anesth Analg 2004;99:85-90
45. Antognini JF, Schwartz K. Exaggerated anesthetic requirements in the preferentially anesthetized brain. Anesthesiology 1993;79:1244-9
46. Violet JM, Downie DL, Nakisa RC, Lieb WR, Franks NP. Differential sensitivities of mammalian neuronal and muscle nicotinic acetylcholine receptors to general anesthetics. Anesthesiology 1997;86:866-74